Testing Adaptive Therapy Protocols using Gemcitabine and Capecitabine on a Mouse Model of Endocrine-Resistant Breast Cancer is a research paper published in Murdoch Research Repository (Murdoch University) (2023). On theSindex it has a DataRank of 0. It has been cited 3 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 3U2CCA233254-01S1
Extension to the HTAN Pre-Cancer Atlas Project
National Institutes of Health
Grant: 5U54CA217376-05
Arizona Cancer and Evolution Center (ACE)
National Institutes of Health
Grant: 5U01CA232382-03
Eco-Evolutionary dynamics of NSCLC to immunotherapy: Response and Resistance
NCI NIH HHS
Grant: U01 CA232382
NCI NIH HHS
Grant: U2C CA233254
NCI NIH HHS
Grant: U54 CA217376
Fields of Study
Keywords